Skip to main content

Table 1 Socio-demographic characteristics, TB and drug use history, and test results of the participants

From: Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial

Characteristic Total Control group Case management group
Male participants (%, 95% CI) 64.9 (55.8-73.9) 61.8 (48.7-74.9) 67.9 (55.4-80.3)
Mean age in years (SD; range) 26.2 (4.2; 19-48) 26.3 (3.1; 20-33) 26.0 (5.2; 19-48)
Sample younger than 30 years of age (%, 95% CI) 83.9 (77.0-90.8) 82.1 (71.9-92.4) 85.7 (76.4-95.1)
Ethnicity (%, 95% CI)    
Estonian 9.8 (4.2-15.4) 8.9 (1.3-16.5) 10.7 (2.5-19.0)
Other 90.2 (84.6-96.8) 91.1 (83.5-98.7) 89.3 (81.0-97.5)
Persons with less than 12 years of education (%, 95% CI) 56.3 (46.9-65.6) 51.8 (38.4-65.1) 60.7 (47.7-73.8)
Percentage of employed participants (%, 95% CI) 49.1 (39.7-58.5) 48.2 (34.9-61.6) 50.0 (36.6-63.4)
Percentage of participants who had been in prison at least once in lifetime (%, 95% CI) 61.6 (52.5-70.6) 67.9 (55.4-80.3) 55.4 (42.1-68.6)
Mean age at initiation of IDU (SD; range) 16.8 (3.3; 11-30) 17.3 (3.6; 11-26) 16.2 (3.0; 11-30)
Mean duration of IDU in years (SD; range) 9.4 (3.6; 2-24) 9.0 (3.4; 2-20) 9.8 (3.8; 4-24)
Percentage uninsured by the national health insurance (%, 95% CI) 36.6 (27.5-45.7) 35.7 (22.9-48.5) 37.5 (24.6-50.4)
Percentage of people with TB contacts (%, 95% CI) 24.1 (16.1-32.2) 66.7 (53.4-79.9) 81.1 (70.4-91.9)
Percentage of people who had had TB (%, 95% CI) 0.0 0.0 0.0
Percentage HIV-antibody positive 86.2 (79.7-92.8) 88.7 (80.0-97.4) 83.9 (74.1-93.7)
Percentage IGRA-positive (%, 95% CI) 7.4 (2.4-12.4) 9.4 (1.4-17.5) 5.5 (0.0-11.6)
Percentage Mantoux-positive (≥5 mm) (%, 95% CI) 17.0 (9.9-24.0) 19.6 (9.0-30.3) 14.3 (4.9-23.6)